Convergent evidence for the antiviral effects of several FDA-approved phenothiazine antipsychotics against SARS-CoV-2 and other coronaviruses.

Convergent evidence for the antiviral effects of several FDA-approved phenothiazine antipsychotics against SARS-CoV-2 and other coronaviruses. Braz J Psychiatry. 2021 Jan 11;: Authors: Machado-Vieira R, Quevedo J, Shahani L, Soares JC PMID: 33440401 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33440401?dopt=Abstract

Source: Revista Brasileira de Psiquiatria - January 11, 2021 Category: Psychiatry Authors: Machado-Vieira R, Quevedo J, Shahani L, Soares JC Tags: Braz J Psychiatry Source Type: research

More News: Coronavirus | Databases & Libraries | Psychiatry | SARS